IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to save this article

Il ruolo della sperimentazione clinica nel processo di sviluppo del farmaco: l'effetto "Arrow" e la competizione tecnologica

Listed author(s):
  • Laura Ferrari Bravo
Registered author(s):

    Il ruolo della sperimentazione clinica nel processo di sviluppo del farmaco: l'effetto "Arrow" e la competizione tecnologica (di Laura Ferrari Bravo) - ABSTRACT: The economic literature on sequential innovations acknowledges that the successful firm earns a monopoly position only until the next innovation arrives. Such a dynamic process - which Schumpeter (1942, p. 83) labeled "creative destruction" - implies that leadership on the market by one firm is only a matter of time, since a new innovating firm will sooner or later displace the former incumbent. In the pharmaceutical industry, this sort of reasoning, which connects to the so-called Arrow effect, conflicts with empirical evidence on leading companies experiencing long lasting high market shares. Since these companies operate at the leading edge of technology by accounting for most of the research done, we believe that at least for the pharmaceutical industry there are elements of the R&D process neglected by the literature on innovation which may question the validity of the Arrow effect. We therefore model the behavior of pharmaceutical firm by introducing the role of clinical trials in shaping R&D decisions.

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

    File URL:
    Download Restriction: Single articles can be downloaded buying download credits, for info:

    As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

    Article provided by FrancoAngeli Editore in its journal STUDI ECONOMICI.

    Volume (Year): 2002/77 (2002)
    Issue (Month): 77 ()

    in new window

    Handle: RePEc:fan:steste:v:html10.3280/ste2002-077009
    Contact details of provider: Web page:

    Order Information: Web: Email:

    No references listed on IDEAS
    You can help add them by filling out this form.

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    When requesting a correction, please mention this item's handle: RePEc:fan:steste:v:html10.3280/ste2002-077009. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Angelo Ventriglia)

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.